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ABSTRACT 
Background/Objectives: Vitamin E is an essential fat-soluble vitamin that has been shown to 
induce favorable effects on animal and human immune systems. The objective of this study 
was to assess the effects of tocotrienol-rich fraction (TRF) supplementation on immune 
response following tetanus toxoid (TT) vaccine challenge in healthy female volunteers.  
Subjects/Methods: In this double-blinded, placebo-controlled clinical trial, participants were 
randomly assigned to receive either placebo (control group) or 400 mg of TRF (study group) 
supplementation daily. Over the 2-month period of the study, volunteers were asked to attend 
three clinical sessions (that is, on days 0, 28 and 56) and blood samples were obtained from 
the volunteers during the follow-up. On day 28, all volunteers were also vaccinated with the 
TT vaccine (20 Lf) intramuscularly.  
Results: The results from the clinical trial showed that TRF supplementation significantly 
increased the total vitamin E level in the plasma of the TRF-supplemented volunteers 
compared with the placebo group, indicating overall compliance. Volunteers supplemented 
with TRF showed a significantly (P0.05) enhanced production of interferon-γ and interleukin 
(IL)-4 by the mitogen or TT-stimulated leukocytes compared with the control group. 
Volunteers from the TRF group produced significantly (P < 0.05) lower amounts of IL-6 
compared with the placebo group. Anti-TT IgG production was also significantly (P < 0.05) 
augmented in the TRF-supplemented group compared with the placebo group.  
Conclusions: We conclude that TRF has immunostimulatory effects and potential clinical 
benefits to enhance immune response to vaccines. 
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